tradingkey.logo

Champions Oncology Inc

CSBR
查看詳細走勢圖
6.550USD
+0.020+0.31%
收盤 02/06, 16:00美東報價延遲15分鐘
90.96M總市值
36.04本益比TTM

Champions Oncology Inc

6.550
+0.020+0.31%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.31%

5天

-10.40%

1月

-0.91%

6月

0.00%

今年開始到現在

-5.21%

1年

-38.56%

查看詳細走勢圖

TradingKey Champions Oncology Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Champions Oncology Inc當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名81/392位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為12.00。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Champions Oncology Inc評分

相關信息

行業排名
81 / 392
全市場排名
205 / 4521
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Champions Oncology Inc亮點

亮點風險
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
業績增長期
公司處於發展階段,最新年度總收入56.94M美元
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值36.04,處於3年歷史高位
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉334.61K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.11

分析師目標

基於 1 分析師
買入
評級
12.000
目標均價
+83.77%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Champions Oncology Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Champions Oncology Inc簡介

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
公司代碼CSBR
公司Champions Oncology Inc
CEOBrainin (Robert)
網址https://championsoncology.com
KeyAI